{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:17:32Z","timestamp":1772770652255,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Concepts surrounding the mechanisms of thrombocytopenia in ITP have shifted from the traditional view of autoantibody mediated platelet destruction to more complex mechanisms in which impaired platelet production, T-cell-mediated effects, and disturbed cytokine profiles play a role. Interleukin 27 (IL-27) plays pleiotropic roles in immunomodulation and autoimmune diseases.<\/jats:p>\n            <jats:p>We aimed to determine the level of IL-27 in patients with ITP and its relationship to patient and disease characteristics as well as disease chronicity and response to treatment.<\/jats:p>\n            <jats:p>Sixty childrens with primary immune thrombocytopenia were consequetively enrolled in this study as well as 20 age and sex matched healthy controls.<\/jats:p>\n            <jats:p>ITP patients had significantly higher levels of IL-27 than controls (770.6 and 373.8\u200apg\/ml, respectively). Patients with acute ITP had the highest levels of IL-27 among patient groups, while patients in remission had the lowest IL-27 levels (860.1and 622.9\u200apg\/ml, respectively). Patients who received IVIG and combined steroids plus IVIG had significantly higher IL-27 levels than others. Patients who received Eltrombopag had significantly lower IL-27 levels than others.<\/jats:p>\n            <jats:p>IL-27 seems to play a role in pathogenesis of childhood ITP. IL-27 can be used as a predictor for disease occurrence as well as responsiveness to treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029504","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T12:06:23Z","timestamp":1656331583000},"page":"e29504","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Contribution of interleukin 27 serum level to pathogenesis and prognosis in children with immune thrombocytopenia"],"prefix":"10.1097","volume":"101","author":[{"given":"Tamer","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Abdel Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermin","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Shehab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hosny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1053\/j.seminhematol.2013.03.013","article-title":"Childhood immune thrombocytopenia\u2013who will spontaneously recover?","volume":"50","author":"Yacobovich","year":"2013","journal-title":"Semin Hematol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40364-015-0045-0","article-title":"Biomarkers for immune thrombocytopenia","volume":"3","author":"Yu","year":"2015","journal-title":"Biomark Res"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fimmu.2019.00940","article-title":"T-cell compartmentalization and functional adaptation in autoimmune inflammation: lessons from pediatric rheumatic diseases","volume":"10","author":"Mijnheer","year":"2019","journal-title":"Front Immunol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-06-580084","article-title":"Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia","volume":"124","author":"Zhou","year":"2014","journal-title":"Blood"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.2011.08614.x","article-title":"Decreased expression of interleukin 27 in immune thrombocytopenia","volume":"153","author":"Liu","year":"2011","journal-title":"Br J Haematol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4274\/Tjh.2012.0049","article-title":"Childhood immune thrombocytopenia: long-term follow-up data evaluated by the criteria of the international working group on immune thrombocytopenic purpura","volume":"31","author":"Evim","year":"2014","journal-title":"Turk J Haematol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.pedneo.2018.10.002","article-title":"Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity","volume":"60","author":"G\u00fcng\u00f6r","year":"2019","journal-title":"Pediatr Neonatol"},{"key":"R8-20250504","first-page":"35","article-title":"Epidemiology of idiopathic thrombocytopenic purpura in children","volume":"2","author":"Nazari","year":"2012","journal-title":"Iranian J Pediatr Hematol Oncol"},{"key":"R9-20250504","first-page":"104","article-title":"Acute immune thrombocytopenic purpura in infants","volume":"1","author":"Hashemi","year":"2011","journal-title":"Iranian J Pediatr Hematol Oncol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"41904207","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/2042098618769587","article-title":"Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety","volume":"9","author":"Gonzalez-Porras","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"E267","DOI":"10.1002\/ajh.24310","article-title":"Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years","volume":"91","author":"Palandri","year":"2016","journal-title":"Am J Hematol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/1110-1067.196177","article-title":"Role of interleukin-27 in immune thrombocytopenic purpura and its impact on disease response","volume":"41","author":"Gad Allah","year":"2016","journal-title":"Egypt J Haematol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.humimm.2011.12.010","article-title":"Elevated interleukin-27 enhances the polarization of Th1\/Tc1 cells and the production of proinflammatory cytokines in primary immune thrombocytopenia","volume":"73","author":"Li","year":"2011","journal-title":"Human Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/sji.12197","article-title":"Increased interleukin 27 promotes Th1 differentiation in patients with chronic immune thrombocytopenia","volume":"80","author":"Li","year":"2014","journal-title":"Scand J Immunol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1160\/TH12-01-0012","article-title":"Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia","volume":"107","author":"Olsson","year":"2012","journal-title":"Thromb Haemost"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:01:17Z","timestamp":1746331277000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":17,"journal-issue":{"issue":"25","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029504","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"2020-11-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}